Evidence map›Paper›PMID 38977203›Full record

ReviewNeurotoxicology2024

Identification of neural-relevant toxcast high-throughput assay intended gene targets: Applicability to neurotoxicity and neurotoxicant putative molecular initiating events.

Cina M Mack, Alethea Tsui-Bowen, Alicia R Smith, Karl F Jensen, Prasada Rao S Kodavanti, Virginia C Moser, William R Mundy, Timothy J Shafer, David W Herr

Abstract readReview
In one paragraph

Review in Neurotoxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review of in vitro approaches for assessing the toxicity of chemical stressors across diverse physiological systems.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cina M MackCenter for Public Health and Environmental Assessment, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: Mack.cina@epa.gov.
Alethea Tsui-BowenRegion 6, US Environmental Protection Agency, Dallas, TX 75270, USA. Electronic address: Tsui-Bowen.alethea@epa.gov.
Alicia R SmithOak Ridge Institute for Science Education, Oak Ridge, TN 37830, USA. Electronic address: Smith.alicia.rose@gmail.com.
Karl F JensenUS Environmental Protection Agency, Research Triangle Park, NC 27711, USA.
Prasada Rao S KodavantiCenter for Public Health and Environmental Assessment, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: Kodavanti.prasada@epa.gov.
Virginia C MoserUS Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: drgingermoser@gmail.com.
William R MundyUS Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: wrmundy@outlook.com.
Timothy J ShaferCenter for Computational Toxicology and Exposure, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: Shafer.tim@epa.gov.
David W HerrCenter for Public Health and Environmental Assessment, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: Herr.david@epa.gov.

Funding

Intramural EPA EPA999999
6 · The paper itself

Abstract

The US EPA's Toxicity Forecaster (ToxCast) is a suite of high-throughput in vitro assays to screen environmental toxicants and predict potential toxicity of uncharacterized chemicals. This work examines the relevance of ToxCast assay intended gene targets to putative molecular initiating events (MIEs) of neurotoxicants. This effort is needed as there is growing interest in the regulatory and scientific communities about developing new approach methodologies (NAMs) to screen large numbers of chemicals for neurotoxicity and developmental neurotoxicity. Assay gene function (GeneCards, NCBI-PUBMED) was used to categorize gene target neural relevance (1 = neural, 2 = neural development, 3 = general cellular process, 3 A = cellular process critical during neural development, 4 = unlikely significance). Of 481 unique gene targets, 80 = category 1 (16.6 %); 16 = category 2 (3.3 %); 303 = category 3 (63.0 %); 97 = category 3 A (20.2 %); 82 = category 4 (17.0 %). A representative list of neurotoxicants (548) was researched (ex. PUBMED, PubChem) for neurotoxicity associated MIEs/Key Events (KEs). MIEs were identified for 375 compounds, whereas only KEs for 173. ToxCast gene targets associated with MIEs were primarily neurotransmitter (ex. dopaminergic, GABA)receptors and ion channels (calcium, sodium, potassium). Conversely, numerous MIEs associated with neurotoxicity were absent. Oxidative stress (OS) mechanisms were 79.1 % of KEs. In summary, 40 % of ToxCast assay gene targets are relevant to neurotoxicity mechanisms. Additional receptor and ion channel subtypes and increased OS pathway coverage are identified for potential future assay inclusion to provide more complete coverage of neural and developmental neural targets in assessing neurotoxicity.

Indexed as

High-Throughput Screening AssaysNeurotoxicity SyndromesAnimalsHumansNeuronsToxicity TestsGene targetKey EventsMolecular Initiating EventsNeurotoxicityToxCast

Identifiers

PMID38977203
PMCPMC11895836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.